261 related articles for article (PubMed ID: 20925652)
21. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
22. Regulation of TGF-β1-Induced Pro-Apoptotic Signaling by Growth Factor Receptors and Extracellular Matrix Receptor Integrins in the Liver.
Ozaki I; Hamajima H; Matsuhashi S; Mizuta T
Front Physiol; 2011; 2():78. PubMed ID: 22028694
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
24. Modulation of the transforming growth factor-beta1-induced Smad phosphorylation by the extracellular matrix receptor beta1-integrin.
Hamajima H; Ozaki I; Zhang H; Iwane S; Kawaguchi Y; Eguchi Y; Matsuhashi S; Mizuta T; Matsuzaki K; Fujimoto K
Int J Oncol; 2009 Dec; 35(6):1441-7. PubMed ID: 19885568
[TBL] [Abstract][Full Text] [Related]
25. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
[TBL] [Abstract][Full Text] [Related]
26. Connective tissue growth factor expression after angiotensin II exposure is dependent on transforming growth factor-β signaling via the canonical Smad-dependent pathway in hypertensive induced myocardial fibrosis.
Wong CKS; Falkenham A; Myers T; Légaré JF
J Renin Angiotensin Aldosterone Syst; 2018; 19(1):1470320318759358. PubMed ID: 29575960
[TBL] [Abstract][Full Text] [Related]
27. Pro-fibrotic phenotype of human skin fibroblasts induced by periostin via modulating TGF-β signaling.
Kanaoka M; Yamaguchi Y; Komitsu N; Feghali-Bostwick CA; Ogawa M; Arima K; Izuhara K; Aihara M
J Dermatol Sci; 2018 May; 90(2):199-208. PubMed ID: 29433908
[TBL] [Abstract][Full Text] [Related]
28. New insights into TGF-β/Smad signaling in tissue fibrosis.
Hu HH; Chen DQ; Wang YN; Feng YL; Cao G; Vaziri ND; Zhao YY
Chem Biol Interact; 2018 Aug; 292():76-83. PubMed ID: 30017632
[TBL] [Abstract][Full Text] [Related]
29. TGF-beta signal transduction and mesangial cell fibrogenesis.
Schnaper HW; Hayashida T; Hubchak SC; Poncelet AC
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F243-52. PubMed ID: 12529270
[TBL] [Abstract][Full Text] [Related]
30. TGF-β/Smad and Renal Fibrosis.
Ma TT; Meng XM
Adv Exp Med Biol; 2019; 1165():347-364. PubMed ID: 31399973
[TBL] [Abstract][Full Text] [Related]
31. Regulation of transforming growth factor-beta signaling.
Zhu HJ; Burgess AW
Mol Cell Biol Res Commun; 2001 Nov; 4(6):321-30. PubMed ID: 11703090
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta-induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarring.
Cutroneo KR
Wound Repair Regen; 2007; 15 Suppl 1():S54-60. PubMed ID: 17727468
[TBL] [Abstract][Full Text] [Related]
33. TGF beta -1, -2 and -3 in the modulation of fibrosis in the cornea and other organs.
Wilson SE
Exp Eye Res; 2021 Jun; 207():108594. PubMed ID: 33894227
[TBL] [Abstract][Full Text] [Related]
34. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.
Wang M; Chen DQ; Wang MC; Chen H; Chen L; Liu D; Zhao H; Zhao YY
Phytomedicine; 2017 Dec; 36():243-253. PubMed ID: 29157821
[TBL] [Abstract][Full Text] [Related]
35. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
36. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent.
Kaviratne M; Hesse M; Leusink M; Cheever AW; Davies SJ; McKerrow JH; Wakefield LM; Letterio JJ; Wynn TA
J Immunol; 2004 Sep; 173(6):4020-9. PubMed ID: 15356151
[TBL] [Abstract][Full Text] [Related]
37. Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis.
Verrecchia F; Mauviel A; Farge D
Autoimmun Rev; 2006 Oct; 5(8):563-9. PubMed ID: 17027893
[TBL] [Abstract][Full Text] [Related]
38. Integrins in cardiac fibrosis.
Li R; Frangogiannis NG
J Mol Cell Cardiol; 2022 Nov; 172():1-13. PubMed ID: 35872324
[TBL] [Abstract][Full Text] [Related]
39. How can transforming growth factor beta be targeted usefully to combat liver fibrosis?
Shek FW; Benyon RC
Eur J Gastroenterol Hepatol; 2004 Feb; 16(2):123-6. PubMed ID: 15075983
[TBL] [Abstract][Full Text] [Related]
40. TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases.
Pardali E; Sanchez-Duffhues G; Gomez-Puerto MC; Ten Dijke P
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29039786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
